Showing results (791-800 of 1,984) with videos related to

Sort By:
Pageof 199
The Lancet. Neurology|September 10, 2013
Preclinical Alzheimer's disease and its outcome: a longitudinal cohort studyStephanie Jb Vos, Chengjie Xiong, Pieter Jelle Visser, et al.
The Lancet. Neurology|September 21, 2013
Posterior circulation ischaemic stroke and transient ischaemic attack: diagnosis, investigation, and secondary preventionHugh S Markus, H Bart van der Worp, Peter M Rothwell
The Lancet. Neurology|August 17, 2013
Dolphins, dogs, and robot seals for the treatment of neurological diseaseAdrian Burton
The Lancet. Neurology|June 25, 2013
Effect of thrombolysis with alteplase within 6 h of acute ischaemic stroke on long-term outcomes (the third International Stroke Trial [IST-3]): 18-month follow-up of a randomised controlled trial
The Lancet. Neurology|April 2, 2013
An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man studyTimothy M Miller, Alan Pestronk, William David, et al.
The Lancet. Neurology|November 27, 2012
Incidence of traumatic brain injury in New Zealand: a population-based studyValery L Feigin, Alice Theadom, Suzanne Barker-Collo, et al.
The Lancet. Neurology|December 3, 2013
Development of the PHASES score for prediction of risk of rupture of intracranial aneurysms: a pooled analysis of six prospective cohort studiesJacoba P Greving, Marieke J H Wermer, Robert D Brown, et al.
The Lancet. Neurology|December 17, 2013
Optic neuritisAhmed T Toosy, Deborah F Mason, David H Miller
The Lancet. Neurology|October 22, 2013
Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extensionClaudia Trenkwalder, Heike Beneš, Ludger Grote, et al.
The Lancet. Neurology|October 5, 2013
Emerging injectable therapies for multiple sclerosisJiwon Oh, Peter A Calabresi
Pageof 199